(NASDAQ: APLT) Applied Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10%.
Applied Therapeutics's revenue in 2024 is -$477,000.On average, 1 Wall Street analysts forecast APLT's revenue for 2024 to be $1,165,527,296, with the lowest APLT revenue forecast at $1,165,527,296, and the highest APLT revenue forecast at $1,165,527,296. On average, 1 Wall Street analysts forecast APLT's revenue for 2025 to be $6,764,629,014, with the lowest APLT revenue forecast at $6,764,629,014, and the highest APLT revenue forecast at $6,764,629,014.
In 2026, APLT is forecast to generate $9,438,485,753 in revenue, with the lowest revenue forecast at $9,438,485,753 and the highest revenue forecast at $9,438,485,753.